Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers
Authors
Keywords
Kinase inhibitors, Crystal structure, Cancer treatment, Breast tumors, Carcinogenesis, Crystallization, Breast cancer, Cell membranes
Journal
PLoS One
Volume 13, Issue 6, Pages e0198374
Publisher
Public Library of Science (PLoS)
Online
2018-06-08
DOI
10.1371/journal.pone.0198374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 Å resolution
- (2016) Manish Kumar Thakur et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation
- (2016) K. Ito et al. CANCER RESEARCH
- Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors
- (2016) Jie Jiang et al. CANCER RESEARCH
- Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer
- (2016) P. S. Mathur et al. MOLECULAR CANCER RESEARCH
- Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition
- (2015) Tiffany Tsui et al. BIOCHEMISTRY
- PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
- (2015) Maoyu Peng et al. Oncotarget
- Discovery of 4-anilino α-carbolines as novel Brk inhibitors
- (2014) Kazem Ahmed Mahmoud et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of ( E )-5-(benzylideneamino)-1 H -benzo[ d ]imidazol-2(3 H )-one derivatives as inhibitors for PTK6
- (2014) Hyun Jae Shim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PTK6 Promotes Cancer Migration and Invasion in Pancreatic Cancer Cells Dependent on ERK Signaling
- (2014) Hiroaki Ono et al. PLoS One
- Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT
- (2012) Y Zheng et al. ONCOGENE
- Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors
- (2011) Hongbo Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel fatty acid synthase (FAS) inhibitors based on the structure of ketoaceyl synthase (KS) domain
- (2011) Xiao-Fei Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Protein-tyrosine Kinase 6 Promotes Peripheral Adhesion Complex Formation and Cell Migration by Phosphorylating p130 CRK-associated Substrate
- (2011) Yu Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein Tyrosine Kinase 6 Directly Phosphorylates AKT and Promotes AKT Activation in Response to Epidermal Growth Factor
- (2010) Y. Zheng et al. MOLECULAR AND CELLULAR BIOLOGY
- PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival
- (2010) Hanna Y. Irie et al. PLoS One
- Oncogenic Functions of PTK6 are Enhanced by Its Targeting to Plasma Membrane But Abolished by Its Targeting to Nucleus
- (2009) H. Ie Kim et al. JOURNAL OF BIOCHEMISTRY
- Overexpression of PTK6 (breast tumor kinase) protein—a prognostic factor for long-term breast cancer survival—is not due to gene amplification
- (2009) Michaela Aubele et al. VIRCHOWS ARCHIV
- Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
- (2008) M Aubele et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More